Literature DB >> 9630308

Degree of hypercoagulability and hyperfibrinolysis is related to organ failure and prognosis after burn trauma.

A García-Avello1, J A Lorente, J Cesar-Perez, L J García-Frade, R Alvarado, J M Arévalo, J L Navarro, A Esteban.   

Abstract

Severely burned patients often present a hypercoagulability situation. However, its magnitude, time course, and relationship with organ failure and outcome remains to be established. Forty-three patients were studied on the first and seventh day after burn for hypercoagulability and fibrinolysis parameters. A hypercoagulability and hyperfibrinolysis state was found the first day after burn demonstrated by high levels of activated factor VII (VIIa, p<0.01), thrombin-antithrombin III complex (TAT, p<0.01), tissue plasminogen activator (t-PA, p<0.001) and D dimer (DD, p<0.01) and low levels of antithrombin III (ATIII, p<0.01), protein C (PC, p<0.01), plasminogen (PG, p<0.001) and alpha2 antiplasmin (AP, p<0.001). A paradoxical coexisting hypofibrinolysis was found as suggested by a low global fibrinolytic activity in the euglobulin plasma fraction fibrin plate assay (FA, p<0.01) and high levels of tissue plasminogen activator inhibitor type 1 (PAI-1, p<0.01). On day 7, a less marked hypercoagulability situation was found, with low ATIII (p<0.01) and PC (p<0.01), persisting the hypofibrinolytic situation observed on the first day. Non-survivors (NS) showed higher levels of VIIa (p<0.01), TAT (p<0.05) and t-PA (p<0.05), and lower levels of ATIII (p<0.05), PC (p<0.05) and AP (p<0.001) than survivors (S) on the first day. Also, there was a positive correlation of Marshall organ failure score with ATIII, (r2=0.49, p<0.001), PC, (r2=0.14, p<0.045) and PG levels, (r2=0.41, p<0.0003). Severely burned patients show a state of transient disseminated intravascular coagulation, related to the development of organ failure and outcome.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9630308     DOI: 10.1016/s0049-3848(97)00291-0

Source DB:  PubMed          Journal:  Thromb Res        ISSN: 0049-3848            Impact factor:   3.944


  20 in total

1.  Monitoring and treatment of coagulation abnormalities in burn patients. an international survey on current practices.

Authors:  A Lavrentieva; N Depetris; E Kaimakamis; M Berardino; M Stella
Journal:  Ann Burns Fire Disasters       Date:  2016-09-30

2.  Early leukocyte gene expression associated with age, burn size, and inhalation injury in severely burned adults.

Authors:  Ravi F Sood; Nicole S Gibran; Brett D Arnoldo; Richard L Gamelli; David N Herndon; Ronald G Tompkins
Journal:  J Trauma Acute Care Surg       Date:  2016-02       Impact factor: 3.313

3.  Analysis of factor XIa, factor IXa and tissue factor activity in burn patients.

Authors:  Jeffrey W Shupp; Shannon M Prior; Daniel Y Jo; Lauren T Moffatt; Kenneth G Mann; Saulius Butenas
Journal:  Burns       Date:  2017-10-09       Impact factor: 2.744

Review 4.  Antithrombin in the treatment of burn trauma.

Authors:  Areta Kowal-Vern; Bruce A Orkin
Journal:  World J Crit Care Med       Date:  2016-02-04

5.  Antithrombin III Prevents Early Bacterial Translocation in Burn Injury.

Authors:  O Herek; M Yılmaz; I Kaleli; N Cevahir; N Demirkan
Journal:  Ann Burns Fire Disasters       Date:  2006-12-31

Review 6.  Insulin resistance postburn: underlying mechanisms and current therapeutic strategies.

Authors:  Gerd G Gauglitz; David N Herndon; Marc G Jeschke
Journal:  J Burn Care Res       Date:  2008 Sep-Oct       Impact factor: 1.845

7.  Antithrombin attenuates vascular leakage via inhibiting neutrophil activation in acute lung injury.

Authors:  Sebastian Rehberg; Yusuke Yamamoto; Linda E Sousse; Collette Jonkam; Yong Zhu; Lillian D Traber; Robert A Cox; Donald S Prough; Daniel L Traber; Perenlei Enkhbaatar
Journal:  Crit Care Med       Date:  2013-12       Impact factor: 7.598

8.  Early coagulation disorders after severe burn injury: impact on mortality.

Authors:  Athina Lavrentieva; Theodore Kontakiotis; Militsa Bitzani; Georgia Papaioannou-Gaki; Angeliki Parlapani; Olimpia Thomareis; Nicolaos Tsotsolis; Maria-Amalia Giala
Journal:  Intensive Care Med       Date:  2008-01-12       Impact factor: 17.440

9.  Impact of Platelets and Platelet-Derived Microparticles on Hypercoagulability Following Burn Injury.

Authors:  Emily F Midura; Joshua W Kuethe; Teresa C Rice; Rosalie Veile; Lisa G England; Lou Ann Friend; Charles C Caldwell; Michael D Goodman
Journal:  Shock       Date:  2016-01       Impact factor: 3.454

10.  Abnormal insulin sensitivity persists up to three years in pediatric patients post-burn.

Authors:  Gerd G Gauglitz; David N Herndon; Gabriela A Kulp; Walter J Meyer; Marc G Jeschke
Journal:  J Clin Endocrinol Metab       Date:  2009-02-24       Impact factor: 5.958

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.